- Home
- CAPR vs PBT Comparison
CAPR vs PBT Comparison
Compare CAPR & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- PBT
- Stock Information
- Founded
- CAPR 2005
- PBT 1980
- Country
- CAPR United States
- PBT United States
- Employees
- CAPR N/A
- PBT N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- PBT Oil & Gas Production
- Sector
- CAPR Health Care
- PBT Energy
- Exchange
- CAPR Nasdaq
- PBT Nasdaq
- Market Cap
- CAPR 622.9M
- PBT 470.7M
- IPO Year
- CAPR N/A
- PBT N/A
- Fundamental
- Price
- CAPR $12.79
- PBT $9.89
- Analyst Decision
- CAPR Strong Buy
- PBT
- Analyst Count
- CAPR 7
- PBT 0
- Target Price
- CAPR $39.29
- PBT N/A
- AVG Volume (30 Days)
- CAPR 1.5M
- PBT 126.0K
- Earning Date
- CAPR 03-19-2025
- PBT 01-01-0001
- Dividend Yield
- CAPR N/A
- PBT 5.01%
- EPS Growth
- CAPR N/A
- PBT 25.21
- EPS
- CAPR N/A
- PBT 0.78
- Revenue
- CAPR $23,228,045.00
- PBT $37,735,284.00
- Revenue This Year
- CAPR N/A
- PBT N/A
- Revenue Next Year
- CAPR $74.85
- PBT N/A
- P/E Ratio
- CAPR N/A
- PBT $12.98
- Revenue Growth
- CAPR 65.33
- PBT 25.46
- 52 Week Low
- CAPR $3.52
- PBT $9.43
- 52 Week High
- CAPR $23.40
- PBT $14.58
- Technical
- Relative Strength Index (RSI)
- CAPR 42.76
- PBT 38.17
- Support Level
- CAPR $11.75
- PBT $9.58
- Resistance Level
- CAPR $16.17
- PBT $10.55
- Average True Range (ATR)
- CAPR 1.51
- PBT 0.53
- MACD
- CAPR -0.18
- PBT -0.03
- Stochastic Oscillator
- CAPR 22.96
- PBT 25.27
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.